Arvas M

ORCID: 0000-0002-6902-8488 · 6 papers in corpus
2024
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14890

IntroductionTo prevent blood donors from developing iron deficiency (ferritin <15 μg/L) and subsequent anemia (hemoglobin <120 g/L), blood services rely on information about known risk factors, including the donor's sex and age. For example…

2023
Nature ·doi:10.1038/s41586-022-05473-8

Population isolates such as those in Finland benefit genetic research because deleterious alleles are often concentrated on a small number of low-frequency variants (0.1% ≤ minor allele frequency < 5%). These variants survived the founding …

article 2018
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology ·doi:10.1080/01443615.2018.1441815

The aim of the study was to reveal the prevalence of concomitant endometriosis in malignant and borderline ovarian tumours. A retrospective analysis was performed of 530 patients with malignant ovarian tumours and 131 with borderline ovaria…

2010
Journal of gynecologic oncology ·doi:10.3802/jgo.2010.21.4.248

ObjectiveTo evaluate the role of lysophosphatidic acid (LPA) as a tumor marker in diagnosis and follow-up of patients with epithelial ovarian cancer.MethodsEighty-seven epithelial ovarian cancer patients, 74 benign ovarian tumor patients, a…

case-report 2003
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1046/j.1525-1438.2003.13188.x

The aim of this study was to document a case of tamoxifen-associated extensive pelvic endometriosis and attract the attention to this side effect of tamoxifen use in the postmenopausal patient. A 74-year-old woman with a history of breast c…

article 2003
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(03)00047-2

ObjectiveTo determine the prevalence of ovarian endometriosis in malignant epithelial ovarian tumours.Study designA retrospective analysis of 160 malignant and 23 borderline ovarian tumours during the period 1995-2001.ResultsFourteen (7.7%)…